Shares of Ameresco, Inc. (NYSE:AMRC – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the sixteen ratings firms that are covering the stock, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among brokers that have covered the stock in the last year is $38.46.
Several research firms recently issued reports on AMRC. Robert W. Baird increased their price target on shares of Ameresco from $32.00 to $42.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. Jefferies Financial Group started coverage on shares of Ameresco in a research report on Wednesday, September 4th. They issued a “hold” rating and a $33.00 target price on the stock. StockNews.com upgraded shares of Ameresco to a “sell” rating in a research report on Tuesday. Piper Sandler cut their target price on shares of Ameresco from $37.00 to $35.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 6th. Finally, UBS Group raised their target price on shares of Ameresco from $39.00 to $40.00 and gave the company a “buy” rating in a research report on Thursday, September 5th.
Check Out Our Latest Analysis on AMRC
Ameresco Stock Performance
Ameresco (NYSE:AMRC – Get Free Report) last posted its quarterly earnings results on Monday, August 5th. The utilities provider reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.15). The firm had revenue of $437.98 million for the quarter, compared to analyst estimates of $373.75 million. Ameresco had a return on equity of 6.25% and a net margin of 3.77%. The business’s revenue was up 33.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.15 EPS. As a group, research analysts expect that Ameresco will post 1.16 earnings per share for the current fiscal year.
Insider Activity
In related news, CFO Spencer Doran Hole sold 5,000 shares of Ameresco stock in a transaction on Monday, August 12th. The shares were sold at an average price of $26.53, for a total transaction of $132,650.00. Following the completion of the transaction, the chief financial officer now owns 1,878 shares of the company’s stock, valued at $49,823.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Over the last 90 days, insiders sold 5,221 shares of company stock valued at $140,814. Insiders own 42.00% of the company’s stock.
Hedge Funds Weigh In On Ameresco
A number of hedge funds have recently bought and sold shares of the company. nVerses Capital LLC acquired a new stake in Ameresco in the second quarter worth $75,000. Point72 DIFC Ltd acquired a new stake in Ameresco in the second quarter worth $86,000. GAMMA Investing LLC grew its holdings in Ameresco by 1,215.2% in the second quarter. GAMMA Investing LLC now owns 3,117 shares of the utilities provider’s stock worth $90,000 after purchasing an additional 2,880 shares during the period. SG Americas Securities LLC acquired a new stake in Ameresco in the second quarter worth $156,000. Finally, Northside Capital Management LLC acquired a new stake in Ameresco in the second quarter worth $216,000. Institutional investors own 99.24% of the company’s stock.
Ameresco Company Profile
Ameresco, Inc, a clean technology integrator, provides a portfolio of energy efficiency and renewable energy supply solutions in the United States, Canada, Europe, and internationally. It operates through U.S. Regions, U.S. Federal, Canada, Europe, Alternative Fuels, and All Other segments. The company offers energy efficiency, infrastructure upgrades, energy security and resilience, asset sustainability, and renewable energy solutions for businesses and organizations.
See Also
- Five stocks we like better than Ameresco
- Health Care Stocks Explained: Why You Might Want to Invest
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Best Stocks Under $10.00
- 2 Energy Stocks Fueling the AI Datacenter Boom
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Ameresco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ameresco and related companies with MarketBeat.com's FREE daily email newsletter.